Geron Corp (LTS:0IV3)
$ 1.25 -0.15 (-10.71%) Market Cap: 827.56 Mil Enterprise Value: 637.23 Mil PE Ratio: 0 PB Ratio: 3.61 GF Score: 46/100

Q1 2026 Geron Corp Earnings Call Transcript

May 06, 2026 / 12:00PM GMT
Release Date Price: $1.69 (+4.97%)
Operator

Hello, and welcome to Geron Corporation first quarter 2026 earnings call. (Operator Instructions) Please advised that today's conference will be recorded.

I'll now turn the call over to Dawn Schottlandt, Senior Vice President, Investor Relations and Corporate Affairs. You may begin.

Dawn Schottlandt
Geron Corp - Senior Vice President - Investor Relations and Corporate Affairs

Good morning, everyone. Welcome to the Geron Corporation first quarter 2026 earnings conference call. Before we begin, please note that during the course of this presentation and question-and-answer session, we will be making forward-looking statements regarding future events, performance plans, expectations, and other projections, including those relating to our 2026 financial guidance, our current RYTELO commercialization strategy, and related opportunities in the US and the EU, the therapeutic potential of RYTELO, other anticipated clinical and commercial events and related timelines, the sufficiency of our financial resources, and other statements that are not historical

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot